{"id":"W2077037832","doi":"10.1016/j.clbc.2013.10.016","title":"Randomized Phase II Trial of the Cyclin-Dependent Kinase Inhibitor Dinaciclib (MK-7965) Versus Capecitabine in Patients With Advanced Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Clinical Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"Merck","keywords":"Medicine; Capecitabine; Oncology; Breast cancer; Randomized controlled trial; Internal medicine; Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007102184,0.0006379546,0.002266287,0.0001544913,0.0001569206,0.0000258363,0.000470214,0.0003042762,0.00222313],"category_scores_gemma":[0.0004231244,0.0003841194,0.0006500065,0.0006852327,0.001229274,0.0004661818,0.0002714677,0.0009508395,0.00002218536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005928298,"about_ca_system_score_gemma":0.0007476647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001163199,"about_ca_topic_score_gemma":0.0003615925,"domain_scores_codex":[0.9945728,0.0004593972,0.002074622,0.0009873607,0.001094853,0.0008109654],"domain_scores_gemma":[0.9956139,0.0008202872,0.001082149,0.001119168,0.0008877214,0.0004767854],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.766441,0.004497262,0.02904811,0.00006999733,0.0004461997,0.00000613363,0.0001158161,0.00008606171,0.0002419787,0.00002208495,0.0001234299,0.198902],"study_design_scores_gemma":[0.8377685,0.001861849,0.1575958,0.0008721678,0.0004719827,0.000009660178,0.0001045659,0.00007627709,0.0002527585,0.00006646404,0.0004982018,0.0004218085],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9829748,0.0006048027,0.00002273122,0.006465147,0.003384894,0.005560443,0.0007192072,0.00007835169,0.0001896338],"genre_scores_gemma":[0.9945513,0.0003302591,0.0002199111,0.0008281284,0.001444783,0.002057454,0.00003394544,0.0001203025,0.0004139306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1984802,"threshold_uncertainty_score":0.9998611,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02014164253463134,"score_gpt":0.3471441605379508,"score_spread":0.3270025180033195,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}